InnoPharma announced the launch of Cosyntropin Injection, the generic version of Amphastar’s Cortrosyn. Cortrosyn injection is a synthetic ACTH intended for use as a diagnostic agent in the screening ...
ANI Pharmaceuticals is transitioning into a rare disease therapeutics business, with Cortrosyn and ILUVIEN as key assets. The rare disease segment is expected to comprise 50% of the company’s 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results